STAA - スタ―サ―ジカル (STAAR Surgical Company)

STAAのニュース

   STAAR Surgical (NASDAQ:STAA) Rating Increased to Strong-Buy at BidaskClub  2020/10/25 05:02:49 The Lincolnian
STAAR Surgical (NASDAQ:STAA) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Friday, BidAskClub reports. Several other research analysts have also recently weighed in on the company. BTIG Research reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Friday, […]
   STAAR Surgical to Report Third Quarter Results on November 4, 2020  2020/10/21 11:00:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended October 2, 2020 on Wednesday, November 4, 2020 after the market close. STAAR will host a conference call and webcast on Wednesday, November 4 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operat
   STAAR Surgical (NASDAQ:STAA) Rating Increased to Buy at ValuEngine  2020/10/21 05:34:43 Zolmax News
STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, ValuEngine reports. A number of other brokerages have also recently issued reports on STAA. Sidoti upgraded STAAR Surgical from a “neutral” rating to a “buy” rating and set […]
   STAAR Surgical (NASDAQ:STAA) Expected to Post Quarterly Sales of $43.40 Million  2020/10/20 16:56:42 Transcript Daily
Wall Street analysts expect that STAAR Surgical (NASDAQ:STAA) will announce $43.40 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for STAAR Surgical’s earnings, with estimates ranging from $43.30 million to $43.50 million. STAAR Surgical reported sales of $39.06 million during the same quarter last year, which would suggest […]
   DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against STAAR Surgical Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/10/16 18:58:37 NewMediaWire
Los Angeles, CA - (NewMediaWire) - October 16, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ: STAA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 26, 2020 and August 10, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before October 19, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Notice of Lead Plaintiff Deadline for Shareholders in the STAAR Surgical Company Class Action Lawsuit  2020/08/24 13:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the Central District of California on behalf of purchasers of STAAR Surgical Company (NASDAQ:STAA) common stock between February 26, 2020 and August 10, 2020 (the “Class Period”). The case is captioned Alwazzan v. STAAR Surgical Company, No. 20-cv-01533, and is assigned to Judge James V. Selna. The STAAR Surgical class action lawsuit charges STAAR Surgical and certain of its
   STAA INVESTOR ALERT: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Staar Surgical Company  2020/08/21 20:04:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the common stock of Staar Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) between February 26, 2020, and August 10, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act
   Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of STAAR Surgical Company (STAA) Investors  2020/08/21 20:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $STAA #classaction--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of STAAR Surgical Company (STAA) Investors
   STAA SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies STAAR Surgical Company of Class Action and Encourages Investors to Contact the Firm  2020/08/21 15:00:00 PR Newswire
NEW YORK, Aug. 21, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain of its officers, on behalf of shareholders…
   INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against STAAR Surgical Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/08/21 01:20:22 NewMediaWire
Los Angeles, CA - (NewMediaWire) - August 20, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ: STAA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 26, 2020 and August 10, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before October 19, 2020. If you are a shareholder who suffered a loss, click here to participate.We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Earnings Preview: Staar Surgical (STAA) Q1 Earnings Expected to Decline  2020/04/29 16:34:34 Zacks Investment Research
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   STAAR Surgical to Report First Quarter Results on May 6, 2020  2020/04/15 11:00:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 3, 2020 on Wednesday, May 6, 2020 after the market close. STAAR will host a conference call and webcast on Wednesday, May 6 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progre
   STAAR Surgical Provides COVID-19 Business Update  2020/04/13 11:00:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern. “We have made the decision to get out in front of our traditional earnings call communications to let you know how STAAR is faring during the COVID-19 pandemic. It is clear that the health and safety of everyone ar
   STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results  2020/02/26 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended January 3, 2020. Fourth Quarter 2019 Overview Net Sales of $38.9 Million Up 25% from the Prior Year Quarter ICL Sales of $33.3 Million Up 27% and Units Up 27% from the Prior Year Quarter Gross Margin at 74.1% vs. 73.7% in the Prior
   Stock To Watch: STAAR Surgical Company (STAA)  2020/02/12 23:57:00 RTT News
Shares of STAAR Surgical Company (STAA) have gained nearly 14 percent so far this month in the run-up to the release of financial results for the fourth quarter and fiscal year ended January 3, 2020, slated for February 26, 2020.

calendar